Indaptus Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell INDP and other ETFs, options, and stocks.

About INDP

Indaptus Therapeutics, Inc. is a pre-clinical biotechnology company. It engages in the development of a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. 

CEO
Jeffrey A. Meckler
CEOJeffrey A. Meckler
Employees
7
Employees7
Headquarters
New York, New York
HeadquartersNew York, New York
Founded
Founded
Employees
7
Employees7

INDP Key Statistics

Market cap
3.65M
Market cap3.65M
Price-Earnings ratio
-0.09
Price-Earnings ratio-0.09
Dividend yield
Dividend yield
Average volume
22.85K
Average volume22.85K
High today
$4.77
High today$4.77
Low today
$3.30
Low today$3.30
Open price
$4.00
Open price$4.00
Volume
132.48K
Volume132.48K
52 Week high
$58.24
52 Week high$58.24
52 Week low
$3.21
52 Week low$3.21

INDP News

TipRanks 2d
Indaptus Therapeutics Reports Mixed Results in Clinical Trial

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to...

People also own

Based on the portfolios of people who own INDP. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.